Medicare Enrolled
Dr. Jingdong Su
Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Su from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Su?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Su
Dr. Jingdong Su is an internal medicine specialist in Tyler, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Su performed 132,143 Medicare services across 5,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Su received a total of $11,285 from 63 pharmaceutical and/or device companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Su is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 0% volume in TX
$11,285 industry payments
Medicare Practice Summary
Medicare Utilization ↗132,143
Medicare services
Top 0% in TX for internal medicine
5,128
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 24,480 | $0 | $5 |
| Oxaliplatin chemotherapy injection | 13,900 | $0 | $33 |
| Nivolumab injection (Opdivo) | 13,880 | $24 | $76 |
| Pembrolizumab injection (Keytruda) | 12,800 | $43 | $136 |
| Paclitaxel chemotherapy injection | 11,094 | $0 | $8 |
| Darbepoetin injection (Aranesp) for anemia | 8,935 | $2 | $20 |
| Iron sucrose injection (Venofer) | 7,000 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 6,760 | $0 | $3 |
| Daratumumab injection (Darzalex) | 5,940 | $37 | $127 |
| Dexamethasone injection (steroid) | 3,451 | $0 | $1 |
| Immune globulin infusion (Octagam) | 3,260 | $33 | $233 |
| Injection, docetaxel, 1 mg | 2,518 | $0 | $66 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $18 | $65 |
| Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,590 | $24 | $155 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,179 | $24 | $181 |
| Blood draw (venipuncture) | 1,167 | $8 | $20 |
| Comprehensive metabolic blood panel | 1,100 | $10 | $64 |
| Complete blood count (CBC) with differential | 1,068 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 1,030 | $0 | $24 |
| Office visit, established patient (30-39 min) | 878 | $90 | $368 |
| Injection of additional new drug or substance into vein | 692 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 640 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 512 | $3 | $25 |
| Injection, fluorouracil, 500 mg | 484 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 455 | $96 | $707 |
| Injection, carboplatin, 50 mg | 422 | $2 | $300 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 345 | $3 | $373 |
| Injection, zoledronic acid, 1 mg | 333 | $7 | $431 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 324 | $92 | $1,348 |
| Injection, potassium chloride, per 2 meq | 270 | $0 | $1 |
| Immunoglobulin level test | 243 | $9 | $56 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 221 | $22 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 216 | $46 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 171 | $1 | $7 |
| Injection, cisplatin, powder or solution, 10 mg | 164 | $2 | $94 |
| Cyclophosphamide, 100 mg | 164 | $16 | $203 |
| Injection, magnesium sulfate, per 500 mg | 156 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 149 | $49 | $344 |
| Administration of chemotherapy into vein, each additional hour | 148 | $21 | $161 |
| Ferritin level test (iron stores) | 141 | $13 | $60 |
| Drug injection, under skin or into muscle | 130 | $10 | $96 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 123 | $271 | $2,762 |
| Iron level test | 115 | $6 | $27 |
| Iron binding capacity test | 115 | $9 | $35 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 112 | $54 | $211 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 105 | $350 | $1,722 |
| Magnesium level test | 90 | $7 | $29 |
| Unclassified drugs | 77 | $1 | $8 |
| Microscopic examination for white blood cells with manual cell count | 71 | $4 | $22 |
| Complete blood count (CBC), automated | 71 | $6 | $34 |
| Reticulated (young) platelet measurement | 71 | $33 | $143 |
| New patient office visit, complex (60-74 min) | 69 | $153 | $709 |
| Ct scan of chest with contrast | 67 | $48 | $821 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 64 | $70 | $70 |
| Hospital follow-up visit, high complexity | 60 | $88 | $357 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 59 | $15 | $100 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 53 | $122 | $500 |
| Infusion, normal saline solution , 1000 cc | 49 | $2 | $19 |
| PSA test (prostate cancer screening) | 43 | $18 | $94 |
| CT scan of abdomen and pelvis with contrast | 42 | $156 | $1,067 |
| Irrigation of implanted venous access drug delivery device | 38 | $18 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 37 | $15 | $94 |
| Vitamin B-12 level test | 34 | $15 | $76 |
| Carcinoembryonic antigen (cea) protein level | 33 | $19 | $99 |
| Lactate dehydrogenase (enzyme) level | 33 | $6 | $31 |
| Application of on-body injector for under skin injection | 27 | $14 | $96 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 27 | $25 | $145 |
| Administration of additional new drug or substance into vein using push technique | 23 | $42 | $289 |
| Manual urinalysis test with examination using microscope, non-automated | 22 | $4 | $26 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 21 | $178 | $700 |
| Urea nitrogen level to assess kidney function, quantitative | 20 | $4 | $24 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 20 | $1 | $19 |
| Drawing of blood for a medical problem | 19 | $55 | $264 |
| Infusion into a vein for hydration, each additional hour | 18 | $10 | $75 |
| Office visit, established patient, complex (40-54 min) | 17 | $124 | $496 |
| Red blood count, automated test | 15 | $4 | $23 |
| Infusion into a vein for hydration, 31-60 minutes | 15 | $23 | $256 |
| Initial hospital admission, high complexity | 15 | $133 | $694 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $91 | $657 |
| Ct scan of abdomen and pelvis before and after contrast | 14 | $185 | $1,413 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 14 | $1,103 | $4,802 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.5% high complexity
73.8% medium
4.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,285
Total received (2018-2024)
Avg $1,612/year across 7 years
Top 8% in TX for internal medicine
63
Companies
259
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,102 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$183 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,901
2023
$2,100
2022
$469
2021
$81
2020
$263
2019
$2,522
2018
$2,950
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,651
Janssen Biotech, Inc.
$771
Novartis Pharmaceuticals Corporation
$561
Amgen Inc.
$549
Merck Sharp & Dohme Corporation
$478
Genentech USA, Inc.
$419
GlaxoSmithKline, LLC.
$371
E.R. Squibb & Sons, L.L.C.
$310
Janssen Scientific Affairs, LLC
$290
Takeda Pharmaceuticals U.S.A., Inc.
$265
PFIZER INC.
$261
Tempus AI, Inc
$251
Puma Biotechnology, Inc.
$246
Exelixis Inc.
$244
ABBVIE INC.
$229
Lilly USA, LLC
$224
Astellas Pharma US Inc
$210
TESARO, Inc.
$209
AbbVie, Inc.
$202
Stemline Therapeutics Inc.
$197
Incyte Corporation
$192
Celgene Corporation
$177
Karyopharm Therapeutics Inc.
$174
Genmab U.S., Inc.
$162
EMD Serono, Inc.
$162
SOBI, INC
$150
Kite Pharma, Inc.
$141
Gilead Sciences, Inc.
$138
BeiGene USA, Inc.
$133
Ipsen Biopharmaceuticals, Inc
$125
Clovis Oncology, Inc.
$125
JAZZ PHARMACEUTICALS INC.
$121
Mirati Therapeutics, Inc.
$114
Alexion Pharmaceuticals, Inc.
$112
Rigel Pharmaceuticals, Inc.
$107
Pharmacyclics LLC, An AbbVie Company
$107
Synergy Pharmaceuticals Inc
$106
Pharmacosmos Therapeutics Inc.
$102
GENZYME CORPORATION
$97
TAIHO ONCOLOGY, INC.
$93
Myriad Genetic Laboratories, Inc.
$91
Seagen Inc.
$87
Regeneron Healthcare Solutions, Inc.
$56
Blueprint Medicines Corporation
$56
Daiichi Sankyo Inc.
$54
MorphoSys, US Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$29
Aveo Pharmaceuticals, Inc.
$28
Tactile Systems Technology Inc
$27
Sun Pharmaceutical Industries Inc.
$24
G1 Therapeutics, Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$20
Shire North American Group Inc
$19
ADC Therapeutics America, Inc.
$18
Iovance Biotherapeutics, Inc.
$17
Sumitomo Pharma America, Inc.
$17
ARRAY BIOPHARMA INC
$16
AbbVie Inc.
$16
Novocure Inc.
$15
Emmaus Medical, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Allergan Inc.
$13
Fortovia Therapeutics, Inc.
$12
Top 3 companies account for 26.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · Amtagvi · BAVENCIO · BOSULIF · BRUKINSA · CALQUENCE · COSELA · Cabometyx · DARZALEX · ELZONRIS · EMPLICITI · EPKINLY · ERBITUX · ERLEADA · Endari · Enhertu · Epkinly · Erleada · FLEXITOUCH · FOTIVDA · GAZYVA · IMBRUVICA · IMFINZI · IMJUDO · Imbruvica · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nerlynx · OJJAARA · ONIVYDE · OPDIVO · ORGOVYX · Onivyde · Optune · Orserdu · PIQRAY · Padcev · REBLOZYL · RYDAPT · Revlimid · Rubraca · SARCLISA · SOMATULINE DEPOT · SUTENT · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Trodelvy · Trulance · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in TX.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Su is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 8% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Su experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Su performed 24,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Su receive payments from pharmaceutical companies?
Yes. Dr. Su received a total of $11,285 from 63 companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Su's costs compare to other internal medicine physicians in Tyler?
Dr. Su's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Su) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Tyler
Browse internal medicine physicians in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology